Paul H.A. Quax

发表

Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: Correlation with metastatic behavior in vivo

P. Quax, J. Schalken, J. Verheijen, 1997, The Prostate.

Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

P. Quax, H. Verspaget, U. Weidle, 1994, The American journal of pathology.

TR3 Orphan Receptor Is Expressed in Vascular Endothelial Cells and Mediates Cell Cycle Arrest

P. Quax, J. Grimbergen, C. D. de Vries, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Natural Killer Cells and CD4+ T-Cells Modulate Collateral Artery Development

P. Eilers, P. Quax, J. H. van Bockel, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Epigenetics in atherosclerosis and inflammation

J. Jukema, P. Quax, Rutger J. Wierda, 2010, Journal of cellular and molecular medicine.

Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.

P. Quax, H. Verspaget, J. Verheijen, 1990, Cancer research.

Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis.

H. Ronday, F. Breedveld, P. Quax, 1997, British journal of rheumatology.

The Migration of Human Smooth Muscle Cells In Vitro Is Mediated by Plasminogen Activation and Can Be Inhibited by α2-Macroglobulin Receptor Associated Protein

J. Verheijen, N. Nieuwenbroek, P. Quax, 1997, Thrombosis and Haemostasis.

Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors

J. Jukema, P. Quax, J. Jukema, 2012, Journal of cellular and molecular medicine.

Annexin A5 Therapy Attenuates Vascular Inflammation and Remodeling and Improves Endothelial Function in Mice

J. Jukema, P. Quax, A. V. van Zonneveld, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Pathway Analysis Using Genome-Wide Association Study Data for Coronary Restenosis – A Potential Role for the PARVB Gene

J. Houwing-Duistermaat, P. Slagboom, A. Kastrati, 2013, PloS one.

Blocking Toll-Like Receptors 7 and 9 Reduces Postinterventional Remodeling via Reduced Macrophage Activation, Foam Cell Formation, and Migration

J. Hamming, J. Jukema, P. Quax, 2012, Arteriosclerosis, thrombosis, and vascular biology.

The -2481C variant allele of the lysine acetyltransferase PCAF is associated with reduced vascular mortality. Results from three independent prospective studies

A. Zwinderman, N. Sattar, R. J. Winter, 2010 .

Epigenetic histone acetylation modifiers in vascular remodelling – new targets for therapy in cardiovascular disease

J. Jukema, B. Heijmans, P. Elsen, 2008, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Restenosis after PCI. Part 1: pathophysiology and risk factors

J. Jukema, J. Verschuren, T. Ahmed, 2012, Nature Reviews Cardiology.

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

A. Smit, P. Quax, G. Hospers, 2006, Human Gene Therapy.

MicroRNA-411 and Its 5'-IsomiR Have Distinct Targets and Functions and Are Differentially Regulated in the Vasculature under Ischemia.

P. Quax, A. Y. Nossent, R. V. van der Kwast, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Restenosis after PCI. Part 2: prevention and therapy

Paul H. A. Quax, J. Wouter Jukema, J. Jukema, 2012, Nature Reviews Cardiology.

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

A. Smit, G. Hospers, W. Sluiter, 2006, Human gene therapy.

Tumor necrosis factor- (cid:1) plays an important role in restenosis development

A. Zwinderman, R. J. Winter, J. Jukema, 2005 .

Wnt but Not BMP Signaling Is Involved in the Inhibitory Action of Sclerostin on BMP‐Stimulated Bone Formation

H. Vrieling, M. Karperien, P. ten Dijke, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.

P. Quax, T. V. van Berkel, J. Kuiper, 1990, The Journal of biological chemistry.

Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review.

T. Stijnen, S. Bergheanu, Tarek A.N. Ahmed, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.

A. Zwinderman, R. D. de Winter, J. Kastelein, 2005, Journal of the American College of Cardiology.